|
|
Previous Article | Table of Contents | Next Article 
Involvement of nuclear factor-kappa B in induction of the interleukin-6
gene by leukemia inhibitory factor
HJ Gruss, MA Brach and F Herrmann
Department of Internal Medicine I, University of Freiburg Medical Center,
Germany.
Recent studies have indicated that the leukemia inhibitory factor (LIF)
induces secretion of interleukin-6 (IL-6) in myeloid cells. We here show
that synthesis of IL-6 by human mononuclear phagocytes exposed to
recombinant human (rh) LIF is preceded by an increase of IL-6 transcript
levels as a result of transcriptional activation of the IL-6 gene. Analysis
of deleted fragments of the IL-6 promoter indicated that transcriptional
activation of the IL-6 promoter was associated with enhanced binding
activity of the transcription factor nuclear factor (NF)-kappa B. Binding
of activation protein (AP)-1 and NF-IL-6, also known to transcriptionally
activate the IL-6 promoter, was not inducible by LIF. Furthermore,
introduction of the NF-kappa B sequence into a heterologous promoter
construct, but not of AP-1- and NF-IL-6- binding sequences, conferred
inducibility by LIF to this promoter. Deletion of the NF-kappa B binding
site in the IL-6 promoter was associated with loss of inducibility by LIF,
lending further support for the notion that the NF-kappa B binding site is
crucial for LIF- mediated induction of the IL-6 promoter. Taken together,
our results show that rhLIF induces IL-6 gene expression in mononuclear
phagocytes through transcriptional gene activation involving NF-kappa B.
Volume 80,
Issue 10,
pp. 2563-2570,
11/15/1992
Copyright © 1992 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Middleton, M. Hamanoue, Y. Enokido, S. Wyatt, D. Pennica, E. Jaffray, R. T. Hay, and A. M. Davies
Cytokine-induced Nuclear Factor Kappa B Activation Promotes the Survival of Developing Neurons
J. Cell Biol.,
January 24, 2000;
148(1):
325 - 332.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Middleton, M. Hamanoue, Y. Enokido, S. Wyatt, D. Pennica, E. Jaffray, R. T. Hay, and A. M. Davies
Cytokine-induced Nuclear Factor Kappa B Activation Promotes the Survival of Developing Neurons
J. Cell Biol.,
January 24, 2000;
148(2):
325 - 332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Pyatt, W. S. Stillman, Y. Yang, S. Gross, J. h. Zheng, and R. D. Irons
An Essential Role for NF-{kappa}B in Human CD34+ Bone Marrow Cell Survival
Blood,
May 15, 1999;
93(10):
3302 - 3308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Retraction of several recent papers from Dr. Friedhelm Herrmann's laboratories.
Blood,
May 15, 1999;
93(10):
3573 - 3573.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bhat-Nakshatri, T. R. Newton, R. Goulet Jr., and H. Nakshatri
NF-kappa B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha
PNAS,
June 9, 1998;
95(12):
6971 - 6976.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|